Literature DB >> 18562419

Current and former ecstasy users report different sleep to matched controls: a web-based questionnaire study.

R L Carhart-Harris1, D J Nutt, M Munafò, S J Wilson.   

Abstract

This study sought to test the association between ecstasy-use and abnormal sleep. An anonymous web-based questionnaire containing questions on drug use and sleep was completed by 1035 individuals. From this large sample, a group of 89 ecstasy users were found who reported very little use of other drugs. This "ecstasy-only" group was further divided into two groups of 31 current users and 58 abstinent users. The subjective sleep of current and former ecstasy-only users was compared with that of matched controls. Patients were asked to rate their sleep according to: 1) sleep quality, 2) sleep latency, 3) night time awakenings and 4) total sleep time. Current ecstasy-only users reported significantly worse sleep quality (P < 0.05) and a greater total sleep time (P < 0.001) than controls. It was inferred that these differences might be due to recovery from the acute effects of the drug. Abstinent ecstasy-only users reported significantly more nighttime awakenings than controls (P < 0.01). These subjective findings are in agreement with the objective findings of previous studies showing persistent sleep abnormalities in ecstasy users.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18562419     DOI: 10.1177/0269881108089599

Source DB:  PubMed          Journal:  J Psychopharmacol        ISSN: 0269-8811            Impact factor:   4.153


  6 in total

1.  Equivalent effects of acute tryptophan depletion on REM sleep in ecstasy users and controls.

Authors:  Robin L Carhart-Harris; David J Nutt; Marcus R Munafo; David M Christmas; Sue J Wilson
Journal:  Psychopharmacology (Berl)       Date:  2009-07-08       Impact factor: 4.530

2.  ERP evidence suggests executive dysfunction in ecstasy polydrug users.

Authors:  C A Roberts; S H Fairclough; J E Fisk; F Tames; C Montgomery
Journal:  Psychopharmacology (Berl)       Date:  2013-03-27       Impact factor: 4.530

3.  Depression, impulsiveness, sleep, and memory in past and present polydrug users of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy).

Authors:  Lynn Taurah; Chris Chandler; Geoff Sanders
Journal:  Psychopharmacology (Berl)       Date:  2013-10-11       Impact factor: 4.530

4.  MDMA induces Per1, Per2 and c-fos gene expression in rat suprachiasmatic nuclei.

Authors:  Rowan P Ogeil; David J Kennaway; Mark D Salkeld; Shantha M W Rajaratnam; Jillian H Broadbear
Journal:  Psychopharmacology (Berl)       Date:  2011-10-26       Impact factor: 4.530

5.  Acute effects of 3,4-methylenedioxymethamphetamine (MDMA) and R(-) MDMA on actigraphy-based daytime activity and sleep parameters in rhesus monkeys.

Authors:  Laís F Berro; Hannah Shields; Melis Odabas-Geldiay; Barbara O Rothbaum; Monica L Andersen; Leonard L Howell
Journal:  Exp Clin Psychopharmacol       Date:  2018-06-25       Impact factor: 3.157

6.  Procedural and declarative memory task performance, and the memory consolidation function of sleep, in recent and abstinent ecstasy/MDMA users.

Authors:  Mark Blagrove; Jennifer Seddon; Sophie George; Andrew C Parrott; Robert Stickgold; Matthew P Walker; Katy A Jones; Michael J Morgan
Journal:  J Psychopharmacol       Date:  2010-07-08       Impact factor: 4.153

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.